Case series of combination of carbon dioxide laser and topical 5-flourouracil for prevention of recurrence of keloid


  • Vivekananda Ittigi Department of Dermatology, GIMS, Gadang, Karnataka, India



CO2 laser, 5-fluorouracil, Keloid, Recurrence


The treatment of keloid has been a challenge, and at times, frustrating because of the recurrence. Hence, it is essential to find treatment modality with least recurrence and good cosmetic results. This study showed the effect of topical 5-fluorouracil following carbon dioxide (CO2) laser excision on recurrence of keloid. Case series of Total 24 patients (20 females and 4 males) of age group 12-56 years having keloid of duration 1-8 years were included in this study. Lesions were present on ear lobes, shoulder, chest, leg. CO2 laser was used in continuous mode to excise the lesions and all patients advised topical 5-FU (5%) once daily application over the lesion in the night, once re-epithelization started, for 4 weeks. The patients were followed up initially at every week for 4 weeks then every 4 weeks for 24 weeks to evaluate the response of treatment.  Of the 24 patients evaluated at 24 weeks, none (0%) showed any sign of recurrence. Out of 22 patients four (18.2%) patients complained of burning sensation/irritation. Three (13.6%) patients of erythema and erosion which cleared with temporary discontinuation of topical 5-FU and completed the 4 weeks of topical therapy. Three (13.6%) patients developed hypopigmentation.  Though response of this combination is encouraging in prevention of recurrence of keloid, recurrence on long term follow up need to be observed.


Brian B, Harlan BC. “Keloids”. J Am Acad Dermatol. 1995;33;117-23.

Robles DT, Moore E, Draznin M, Berg D. Keloid: Pathophysiology and management. Dermatol Online J. 2007;13(3):9.

Kaplane I. Current CO2 laser surgery. Plast Reconstr Surg. 1982;69:552.

Sinclair RJ, Sinclair PJ. Carbon dioxide laser in the treatment of cutaneous disorders. Australas J Dermatol. 1991;32:165-71.

Bailin P. Use of the CO2 laser for non-PWS cutaneous lesions. In Arndt KA, Neo JM, Rosen S (eds): “Cutaneous laser therapy: Principal and methods.” New York: John Wiley and Sons. 1983;187-200.

Apfelberg DB, Master MR, Lash H. Preliminary result of argon and carbon dioxide laser treatment of keloid scar. Laser Surg Med. 1984;4:283-90.

Norris JEC. The effect of carbon dioxide laser surgery on the recurrence of keloid. Plast Reconstr Surg. 1991;87:44-9.

Stern JC, Lucente FE. Carbon dioxide laser excision of earlobe keloids. Arch Otolaryngol Head Neck Surg. 1989;115:1107-11.

Stucker FJ, Shaw GY. An approach to management of keloid. Arch Otolaryngol Head Neck Surg. 1992;118:63-7.

Kantor GR, Wheeland RG, Bailin P. Treatment of earlobe keloids with carbon dioxide laser excision: a report of 16 cases. J Dermatol Surg Oncol. 1985;11:1063-6.

Fitzpatrick ER. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:224-32.

Uppal RS, Khan U, Kakar S. The effects of a single dose of 5- fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extra-lesional excision. Plast Reconstr Surg. 2001;108;1218-24.

Ghoshal K, Jacob ST. An alternative molecular mechanism of action of 5-fluorouracil, a potent anti-cancer drug. Biochem Pharmacol. 1997;53:1569.